ONGOING PARTICIPATION IN MULTICENTER CLINICAL TRIAL AND REGISTRIES

A Phase 3, Open-Label, Multi-Center Study for the Assessment of Myocardial Perfusion using Positron Emission Tomography (PET) Imaging of Flurpiridaz F 18 Injection in Patients with Suspected or Known Coronary Artery Disease (CAD)

ONGOING PARTICIPATION IN MULTICENTER CLINICAL TRIAL AND REGISTRIES

Multi-Center Phase III Clinical Trial of new PET F-18 based perfusion agent compared with current SPECT perfusion methods and coronary angiography.

Site Principal Investigator: Eli Botvinick, MD

Read More